TP53 and hepatocellular carcinoma: Of note, the alteration of TP53 at a higher frequency and poorer immune response was also detectable in the high m6Asig-Score group, consistent with the previous study that TP53 gene mutation could down-regulated HCC immune response (Long et al., 2019).